20.3 C
New York
Sunday, June 7, 2026

Tag: NAT

newssourceFORcompanyinformationcontent1marketreleases

PermitUsNow Assists Kerrville Property Owners with Permitting After Devastating Floods

HOUSTON, July 8, 2025 /PRNewswire/ -- In the wake of the catastrophic floods that struck Kerrville and Kerr County on July 3, 2025, PermitUsNow, a...

Johnson & Johnson Launches VARIPULSE™ Platform across Asia-Pacific, Advancing Atrial Fibrillation Treatment

The VARIPULSE™ Platform is the first Pulsed Field Ablation (PFA) system fully integrated with the CARTO™ 3 electroanatomical mapping system, designed to drive efficiency,...

AI Buddy: Friend or Fad?

What can a purple alien teach us about human relationships? Turns out, more than your average AI chatbot. The alien in question is a...

Zuckerberg Waves Cash at AI Whiz Kids

Mark Zuckerberg is throwing big money around to lure top talent to Meta’s new superintelligence lab. We’re talking up to $300 million over four...

HUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line...

— Approval based on Phase III SACHI Trial results which showed a 66% reduced risk of progression or death as compared to platinum-based chemotherapy —

Miracle Made Silver-Infused Sheets Gain Momentum as Clean Sleep Innovation Expands Across U.S. Market

Silver-Infused Bedding Innovation Gains Ground as Miracle Made® Expands U.S. Reach With Bacteria-Resistant, Temperature-Regulating Sheets Supporting Modern Sleep Hygiene 
Silver-Infused Bedding Innovation Gains Ground as Miracle Made® Expands U.S. Reach With Bacteria-Resistant, Temperature-Regulating Sheets Supporting Modern Sleep Hygiene

Lundbeck receives orphan drug designation in the US and EU for Lu AG13909 for the treatment of patients with congenital adrenal hyperplasia

Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disease1 with an estimated global incidence of approximately 1 in 14,000–18,000 live births2A phase II...

Lundbeck receives orphan drug designation in the US and EU for Lu AG13909 for the treatment of patients with congenital adrenal hyperplasia

Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disease1 with an estimated global incidence of approximately 1 in 14,000–18,000 live births2A phase II...

Pharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to...

For media and investors only

IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European Academy...

SHANGHAI and NANJING, China and SAN FRANCISCO, June 22, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development,...

Duke Energy crews restore power to more than 41,000 after severe storms in Ohio/Kentucky

CINCINNATI, June 19, 2025 /PRNewswire/ -- Duke Energy has restored power to more than 41,000 customers who were affected by severe and damaging storms...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsNAT

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers